Pharmac Message on Mesalazine Tablets
Posted Wednesday September 3, 2025
From 1 July 2025 Pharmac listed Mesalazine 1600mg tablets, Asacol brand.
Due to the current shortage of mesalazine 400mg tablets please consider prescribing mesalazine 1600mg for patients that are taking a 1600mg dose.
This is a Section 29 (unapproved) medicine.
Additional information can be found here - Mesalazine tablets Pharmac website
Gallery
Related Articles
MCNZ - Professional Standards for Physician Associates
Friday July 10, 2026
Share your feedback - closes Thursday 16 July
NZSG Exec Strategic Planning Day
Monday July 6, 2026
In late July the NZSG Executive Committee will be meeting to consider the Strategic Plan for 2027 to 2032
LAST CHANCE TO TAKE PART IN - Understanding Endoscopist Perspectives on CADe in Colonoscopy Guidelines
Monday July 6, 2026
Help shape a clearer understanding of how CADe should be evaluated and implemented in routine colonoscopy practice